• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.MYC 基因拷贝数增加与弥漫性大 B 细胞淋巴瘤中 mRNA 水平升高相关。
Haematologica. 2010 Apr;95(4):597-603. doi: 10.3324/haematol.2009.012864.
2
Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.显色原位杂交鉴定 MYC 基因信号簇与弥漫性大 B 细胞淋巴瘤中拷贝数增加、mRNA 和蛋白相关。
Am J Clin Pathol. 2013 Feb;139(2):242-54. doi: 10.1309/AJCP2Z0TAGMUYJEB.
3
[Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].[原发性中枢神经系统弥漫性大B细胞淋巴瘤患者的生存:bcl-2和C-MYC基因畸变及蛋白过表达的影响以及化疗方案的选择]
Zhonghua Bing Li Xue Za Zhi. 2018 Jan 8;47(1):32-38. doi: 10.3760/cma.j.issn.0529-5807.2018.01.007.
4
[B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].伴有myc与bcl-2/IgH或bcl-6同时易位的B细胞淋巴瘤
Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):584-8.
5
Development of a real-time reverse transcription polymerase chain reaction assay for c-myc expression that allows the identification of a subset of c-myc+ diffuse large B-cell lymphoma.用于c-myc表达的实时逆转录聚合酶链反应检测方法的开发,该方法可鉴定c-myc阳性弥漫性大B细胞淋巴瘤的一个亚组。
Lab Invest. 2003 Feb;83(2):143-52. doi: 10.1097/01.lab.0000057000.41585.fd.
6
An increase in copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens.拷贝数增加对弥漫性大 B 细胞淋巴瘤和高级别淋巴瘤患者具有进行性的负预后影响,这些患者可能从强化治疗方案中获益。
Haematologica. 2020 May;105(5):1369-1378. doi: 10.3324/haematol.2019.223891. Epub 2019 Aug 8.
7
MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.MYC易位和拷贝数增加预示成人弥漫性大B细胞淋巴瘤(DLBCL)预后不良,尤其是生发中心样B细胞(GCB)型。
Histopathology. 2008 Aug;53(2):205-17. doi: 10.1111/j.1365-2559.2008.03076.x.
8
Clinical and Pathologic Correlation of Increased MYC Gene Copy Number in Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤中MYC基因拷贝数增加的临床与病理相关性
Clin Lymphoma Myeloma Leuk. 2016 Dec;16(12):679-683. doi: 10.1016/j.clml.2016.08.017. Epub 2016 Aug 20.
9
The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma.弥漫性大 B 细胞淋巴瘤中 MYC 改变的谱。
Acta Haematol. 2020;143(6):520-528. doi: 10.1159/000505892. Epub 2020 Feb 19.
10
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.MYC 拷贝数增加是弥漫性大 B 细胞淋巴瘤患者的独立预后因素。
Mod Pathol. 2017 Dec;30(12):1688-1697. doi: 10.1038/modpathol.2017.93. Epub 2017 Aug 4.

引用本文的文献

1
Diffuse Large B-Cell Lymphoma with t(1;22)(q21;q11.2) and t(6;18)(p25;q21): A Case Report.伴有t(1;22)(q21;q11.2)和t(6;18)(p25;q21)的弥漫性大B细胞淋巴瘤:一例报告
Reports (MDPI). 2025 Jan 5;8(1):5. doi: 10.3390/reports8010005.
2
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies.高危遗传性多发性骨髓瘤:从分子分类到单克隆抗体和T细胞重定向疗法的创新治疗
Cells. 2025 May 25;14(11):776. doi: 10.3390/cells14110776.
3
Chromogenic mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.显色mRNA原位杂交表达与LMO2蛋白和基因表达相关,并揭示其对弥漫性大B细胞淋巴瘤(NOS)生存的影响。
Cancers (Basel). 2024 Jun 28;16(13):2378. doi: 10.3390/cancers16132378.
4
MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B-cell lymphoma patients.MYC过表达而非MYC/BCL2双重表达可预测大包块弥漫性大B细胞淋巴瘤患者的生存情况。
Cancer Med. 2023 Sep;12(18):18568-18577. doi: 10.1002/cam4.6463. Epub 2023 Aug 28.
5
Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma.利用MYC表达和可溶性白细胞介素受体-2水平开发弥漫性大B细胞淋巴瘤的预后评分系统。
Yonago Acta Med. 2023 Jan 25;66(1):56-66. doi: 10.33160/yam.2023.02.007. eCollection 2023 Feb.
6
Altered pathways and targeted therapy in double hit lymphoma.双打击淋巴瘤中的改变通路和靶向治疗。
J Hematol Oncol. 2022 Mar 18;15(1):26. doi: 10.1186/s13045-022-01249-9.
7
Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies.通过基因-蛋白检测评估 2 级前列腺活检组织中 MYC/PTEN 的状态。
J Mol Diagn. 2021 Aug;23(8):1030-1041. doi: 10.1016/j.jmoldx.2021.05.006. Epub 2021 May 29.
8
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.MYC、BCL2 和 BCL6 的体细胞拷贝数增益可确定侵袭性非生发中心型/生发中心型 DLBCL 患者的亚群。
Blood Cancer J. 2020 Nov 9;10(11):117. doi: 10.1038/s41408-020-00382-3.
9
FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.FBXW7 触发 KMT2D 降解,有利于弥漫性大 B 细胞淋巴瘤细胞的生长。
Cancer Res. 2020 Jun 15;80(12):2498-2511. doi: 10.1158/0008-5472.CAN-19-2247. Epub 2020 Apr 29.
10
MYC's Fine Line Between B Cell Development and Malignancy.MYC 在 B 细胞发育和恶性肿瘤之间的微妙界限。
Cells. 2020 Feb 24;9(2):523. doi: 10.3390/cells9020523.

本文引用的文献

1
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌中人表皮生长因子受体2检测的指南建议
Arch Pathol Lab Med. 2007;131(1):18-43. doi: 10.5858/2007-131-18-ASOCCO.
2
Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.拷贝数异常、MYC活性以及正常B细胞的基因指纹在机制上决定了弥漫性大B细胞淋巴瘤的微小RNA谱。
Blood. 2009 Jun 25;113(26):6681-90. doi: 10.1182/blood-2009-01-202028. Epub 2009 Mar 10.
3
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH).用于乳腺癌的 HER2 基因和染色体 17 着丝粒(CEN17)的自动化明场双原位杂交(BDISH)应用的开发及其与手动双色 HER2 荧光原位杂交(FISH)检测方法的性能比较。
Diagn Pathol. 2008 Oct 22;3:41. doi: 10.1186/1746-1596-3-41.
4
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.MYC易位阴性的经典伯基特淋巴瘤病例:一种涉及微小RNA失调的替代致病机制
J Pathol. 2008 Dec;216(4):440-50. doi: 10.1002/path.2410.
5
C-MYC rearrangements are frequent in aggressive mature B-Cell lymphoma with atypical morphology.C-MYC重排在具有非典型形态的侵袭性成熟B细胞淋巴瘤中很常见。
Int J Clin Exp Pathol. 2008 Jan 1;1(1):65-74.
6
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.基因表达可预测接受R-CHOP治疗的弥漫性大B细胞淋巴瘤石蜡包埋组织的总生存期。
Blood. 2008 Oct 15;112(8):3425-33. doi: 10.1182/blood-2008-02-137372. Epub 2008 Jun 10.
7
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.基于石蜡的6基因模型可预测接受R-CHOP治疗的弥漫性大B细胞淋巴瘤患者的预后。
Blood. 2008 Jun 15;111(12):5509-14. doi: 10.1182/blood-2008-02-136374. Epub 2008 Apr 29.
8
The functional response of upstream DNA to dynamic supercoiling in vivo.体内上游DNA对动态超螺旋的功能反应。
Nat Struct Mol Biol. 2008 Feb;15(2):146-54. doi: 10.1038/nsmb.1372. Epub 2008 Jan 13.
9
Widespread microRNA repression by Myc contributes to tumorigenesis.Myc对微小RNA的广泛抑制作用有助于肿瘤发生。
Nat Genet. 2008 Jan;40(1):43-50. doi: 10.1038/ng.2007.30. Epub 2007 Dec 9.
10
Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.FIR与FUSE DNA结合后二聚化表明了一种c-myc抑制机制。
EMBO J. 2008 Jan 9;27(1):277-89. doi: 10.1038/sj.emboj.7601936. Epub 2007 Dec 6.

MYC 基因拷贝数增加与弥漫性大 B 细胞淋巴瘤中 mRNA 水平升高相关。

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.

机构信息

Department of Pathology, University of Arizona, 1501 N Campbell Avenue, PO Box 245043, Tucson, AZ 85724-5043, USA.

出版信息

Haematologica. 2010 Apr;95(4):597-603. doi: 10.3324/haematol.2009.012864.

DOI:10.3324/haematol.2009.012864
PMID:20378577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2857189/
Abstract

BACKGROUND

Translocations involving the MYC gene and increased MYC mRNA levels are associated with poor outcome in diffuse large B-cell lymphoma. However, the presence of increased MYC gene copy number and/or polysomy of chromosome 8 have not been previously described.

DESIGN AND METHODS

Utilizing dual color chromogenic in situ hybridization, we investigated MYC gene copy and chromosome 8 centromere numbers in 52 cases of diffuse large B-cell lymphoma. Cases were divided into those with "increased" or "not increased" MYC gene copy number for comparison with MYC mRNA levels, Ki-67 values, and survival.

RESULTS

Increased MYC gene copy number was present in 38% of cases. Overall, the average MYC mRNA level was 2398 (range, 342 - 9783) and the percentage of nuclei positive for Ki-67 was 57.5% (range, 20-87%). Within the group with increased MYC copy number, the MYC mRNA values ranged from 816 to 5912 (average, 2843) and the Ki-67 values ranged from 23% to 83% (average, 57%). Within the group with not increased MYC copy number, MYC mRNA values ranged from 342 to 9783 (average, 2118) and the Ki-67 values ranged from 20% to 87% (average, 58%). There was a statistically significant relationship between increased MYC gene copy number and increased MYC mRNA (P=0.034) and a trend toward a relationship between increased mRNA and higher Ki-67 values.

CONCLUSIONS

This is the first report that low level copy number increases are common in diffuse large B-cell lymphoma and that these changes correlate with MYC mRNA in a statistically significant manner. MYC copy number changes are an additional possible molecular mechanism that may result in increased mRNA and, likely, high proliferation and poor outcome.

摘要

背景

涉及 MYC 基因的易位和 MYC mRNA 水平升高与弥漫性大 B 细胞淋巴瘤的不良预后相关。然而,MYC 基因拷贝数增加和/或 8 号染色体三体的存在以前尚未被描述。

设计和方法

利用双色显色原位杂交,我们研究了 52 例弥漫性大 B 细胞淋巴瘤中 MYC 基因拷贝数和 8 号染色体着丝粒数。将病例分为 MYC 基因拷贝数“增加”或“未增加”的病例进行比较,比较指标包括 MYC mRNA 水平、Ki-67 值和生存情况。

结果

38%的病例存在 MYC 基因拷贝数增加。总体而言,平均 MYC mRNA 水平为 2398(范围为 342-9783),Ki-67 阳性核的百分比为 57.5%(范围为 20-87%)。在 MYC 拷贝数增加的组内,MYC mRNA 值范围为 816 至 5912(平均 2843),Ki-67 值范围为 23%-83%(平均 57%)。在 MYC 拷贝数未增加的组内,MYC mRNA 值范围为 342 至 9783(平均 2118),Ki-67 值范围为 20%-87%(平均 58%)。MYC 基因拷贝数增加与 MYC mRNA 增加之间存在统计学显著关系(P=0.034),且 mRNA 增加与 Ki-67 值升高之间存在趋势关系。

结论

这是首次报道在弥漫性大 B 细胞淋巴瘤中常见低水平拷贝数增加,并且这些变化与 MYC mRNA 以统计学显著的方式相关。MYC 拷贝数变化是一种可能的分子机制,可能导致 mRNA 增加,以及高增殖和不良预后。